スズキ ノリユキ
Suzuki Noriyuki
鈴木 紀行 所属 東邦大学 薬学部 薬学科 職種 教授 |
|
論文種別 | 原著 |
言語種別 | 英語 |
査読の有無 | 査読あり |
表題 | PRDX6 augments selenium utilization to limit iron toxicity and ferroptosis. |
掲載誌名 | 正式名:Nature structural & molecular biology ISSNコード:15459985 |
掲載区分 | 国外 |
著者・共著者 | Hiroaki Fujita, Yu-ki Tanaka, Noriyuki Suzuki, Sota Kuno, Yasumitsu Ogra, Kazuhiro Iwai. |
発行年月 | 2024/06/12 |
概要 | Ferroptosis is a form of regulated cell death induced by iron-dependent accumulation of lipid hydroperoxides. Selenoprotein glutathione peroxidase 4 (GPX4) suppresses ferroptosis by detoxifying lipid hydroperoxides via a catalytic selenocysteine (Sec) residue. Sec, the genetically encoded 21(st) amino acid, is biosynthesized from a reactive selenium donor on its cognate tRNA([Ser]Sec). It is thought that intracellular selenium must be delivered 'safely' and 'efficiently' by a carrier protein owing to its high reactivity and very low concentrations. Here, we identified peroxiredoxin 6 (PRDX6) as a novel selenoprotein synthesis factor. Loss of PRDX6 decreases the expression of selenoproteins and induces ferroptosis via a reduction in GPX4. Mechanistically, PRDX6 increases the efficiency of intracellular selenium utilization by transferring selenium between proteins within the selenocysteyl-tRNA([Ser]Sec) synthesis machinery, leading to efficient synthesis of selenocysteyl-tRNA([Ser]Sec). These findings highlight previously unidentified selenium metabolic systems and provide new insights into ferroptosis. |